Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Expert Offers Tips to Control Excessive Sweating

Sweating in the heat, while exercising or when under stress is natural and expected. But if you find yourself excessively sweating in the absence of those...

Concussions in Children Less Likely to Be Related to Sport

For children aged 5 through 12 years with concussion, recreation-related concussion (RRC) and non-sport or recreation-related concussion (non-SRRC) occur...

Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults

With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females,...

Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia A

For children with severe hemophilia A, once-weekly prophylaxis with efanesoctocog alfa is associated with high sustained factor VIII activity, resulting...

Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer

Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study published...

German Patient is 7th Person Probably Cured of HIV

A German man has become the seventh person to apparently be cured of HIV, researchers report. The 60-year-old man, referred to as the “next Berlin...

Studies Support Use of Daily Antibiotic to Prevent STDs in High-Risk Groups

It's long been known that popping the antibiotic doxycycline within 72 hours of a risky sexual encounter can greatly reduce a person's risk for a sexually...

FDA Allows Marketing of Vuse Tobacco-Flavored Vapes

The U.S. Food and Drug Administration on Thursday authorized the sale of the country's best-selling e-cigarette. The agency's decision only applies to...

Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease

CARLSBAD, Calif., July 18, 2024. Ionis Pharmaceuticals, Inc. announced today that it has completed enrollment in the pivotal trial of zilganersen (ION373),...

FDA Clears Investigational New Drug application for muscular dystrophy treatment

MINNEAPOLIS and ST. PAUL, Minn., July 17, 2024. Today, Myogenica, a University of Minnesota startup company, announced U.S. Food and Drug Administration...

Are You & Your Partner in a 'Sleep Divorce?' You're Not Alone

Many couples may be painfully familiar with the scenario: One partner snores loudly all night long, so the other partner seeks better sleep in another...

Orexo Receives a Complete Response Letter Regarding the NDA for OX124, a High-Dose Naloxone Rescue Medication in Development for Opioid Overdose

Uppsala, Sweden – July 16, 2024 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces that the company has received a complete response...

Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton

MALVERN, PA, July 16, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo...

FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

Today, the U.S. Food and Drug Administration and the Federal Trade Commission (FTC) issued warning letters to five companies for illegally selling copycat...

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing...

Read more news...

Recently Added

Recently added consumer and prescribing information: Pyzchiva, Ahzantive, Ohtuvayre, Sofdra, Yimmugo, Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Kisunla Kisunla (donanemab-azbt) is an amyloid beta-directed antibody indicated for the treatment of early symptomatic Alzheimer’s disease.
  • Ahzantive Ahzantive (aflibercept-mrbb) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
  • Nypozi Nypozi (filgrastim-txid) is a leukocyte growth factor biosimilar to Neupogen indicated for the treatment of neutropenia, neutropenia...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development